CERI & KRISP Newsletter Feb/Mar 2022: WHO Director-General, Dr Tedros Adhanom Ghebreyesus visit CERI. We are also selected as one of the Ten Breakthro
In our February/March issue of 2022, we focus on the visit of Director-General, Dr Tedros Adhanom Ghebreyesus, Minister of Health Dr. Joe Phaahla, Higher Education, Science and Innovation Deputy Minister Buti Manamela, the Belgian Minister of Development Cooperation, Meryame Kitirto to CERI’s new facilities at Stellenbosch University. We also highlight our selection on the Ten Breakthrough Technologies of 2022 by MIT and the Abbott Pandemic Defense Coalition program to identify novel pathogens and respond to prevent and /or mitigate the impact of the next pandemic
This issue's highlights are:
The concept behind this newsletter is that anyone with 15 minutes to spare can learn about the work of the Centre for Epidemic Research and Innovation (CERI) at Stellenbosch University and the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), which is a Platform of the Technology Innovation Agency (TIA) at University of KwaZulu-Natal (UKZN), Durban, South Africa.
- News: Dr. Tedros, Director-General WHO visits CERI at Stellenbosch University
- News: Our work highlighted as one of Ten Breakthrough Technologies of 2022, MIT
- News: How dangerous is the new Omicron sub-variant?, Financial Times
- News: The Abbott Pandemic Defense Coalition: a multi-sector approach to global pandemic
- PhD graduate: Dr. Vagner Fonseca completes a Ph.D. with 38 publications and a job at PAHO/WHO
- Seminar: Host genetics susceptibility to infectious diseases, Prof Marlo Moller, 9 Mar 2022.
- Seminar: Host genetics susceptibility to infectious diseases, Prof Marlo Moller, 9 Mar 2022
- Publications: Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection. SSRN 2022
- Publications: Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests. J Clin Virol. 2022
CERI and KRISP want to want to challenge the status quo and create a scientific environment in South Africa that drives innovations in global health and reverses the brain drain. A critical function of CERI and KRISP will be to make genomics, epigenetics, and bioinformatics accessible to academic, industrial, and commercial users.
News date: 2022-03-01
Links:
http://www.krisp.org.za/manuscripts/CERI_KRISPnewsletter_Vol5(2)_FebMar.pdf